Clinical Trial Update: Ipilimumab-induced Lung Toxicity: Observational Study

View source ↗

Summary

Observational study assessing the risk and characteristics of ipilimumab-associated lung toxicity in patients with metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)

Snippet

Sponsor: University of Zurich | Conditions: Metastatic Melanoma | Status: COMPLETED